ARS Pharmaceuticals, Inc. (SPRY) ownership: Top institutional holder: RA CAPITAL MANAGEMENT, L.P. ($87.21M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10860977.00 | $87.21M | 2026-03-31 |
| ORBIMED ADVISORS LLC | 8288510.00 | $66.56M | 2026-03-31 |
| Rubric Capital Management LP | 8000000.00 | $64.24M | 2026-03-31 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 7503812.00 | $60.26M | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 5982919.00 | $48.04M | 2026-03-31 |
| VANGUARD GROUP INC | 3509174.00 | $40.88M | 2025-12-31 |
| BlackRock, Inc. | 5012254.00 | $40.25M | 2026-03-31 |
| Aberdeen Group plc | 4113617.00 | $33.03M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-01-02 | |
| Sell | null | 2026-01-02 | |
| Sell | null | 2026-01-02 | |
| Sell | null | 2026-01-02 |
Back to SPRY overview · SPRY earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.